Danish researchers report that high levels of transferrin may contribute to the destruction of insulin-producing beta cells in the pancreas. Transferrin is a glycoprotein that binds with iron and transfers it to cells.
In this new column, "Have You Noticed This About Your Diabetes?" readers send in observations and questions, and, in response, other readers share similar and not-so-similar experiences by posting in the "Comments" section.
Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.
People with diabetes who receive treatment for gum disease can enjoy substantial reductions in hospitalizations, doctor visits, and annual medical expenses according to a study conducted by the University of Pennsylvania and dental insurer United Concordia Dental.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.